From bone marrow to microglia: barriers and avenues

Nathalie Davoust1, Carine Vuaillat, Geraldine Androdias

  • 1INSERM U851, IFR Biosciences, University of Lyon, 69007 Lyon, France.

Trends in Immunology
|April 9, 2008
PubMed

Insights

Microglia, the brain's immune cells, are continuously replenished by bone marrow cells, especially during neurological disease. This study re-evaluates microglial origins and therapeutic potential in the inflamed central nervous system (CNS).

Area of Science:

  • Neuroimmunology
  • Cellular Biology
  • Neuroscience

Background:

  • Microglia are unique macrophages residing in the brain.
  • Their role in central nervous system (CNS) disorders is recognized, but their renewal process remains controversial.
  • Previous studies suggested microglia are replenished by bone marrow-derived cells, a process accelerated in neurological conditions.

Purpose of the Study:

  • To re-evaluate the origins of microglia in the inflamed CNS.
  • To discuss therapeutic strategies based on adult microglial lineage.

Main Methods:

  • Review and re-evaluation of existing studies on microglial turnover.
  • Analysis of bone marrow chimera studies.
  • Consideration of recent work questioning irradiation/reconstitution experiments.

Main Results:

  • Evidence suggests microglia are continuously replenished by bone marrow-derived cells.
  • Microglial turnover is significantly accelerated under various neurological conditions.
  • Concerns exist regarding the interpretation of data from irradiation/reconstitution experiments.

Conclusions:

  • A re-evaluation of microglial origins in the inflamed CNS is necessary.
  • The demonstration of an adult microglial lineage from bone marrow to brain offers therapeutic perspectives.
  • Understanding microglial renewal is crucial for developing treatments for CNS disorders.